Melanocortin receptor agonist for CNS and receptor pathway research.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist active at MC1R and MC4R. Used in CNS pathway research, receptor pharmacology, and melanocortin system studies. ≥99% purity by HPLC, MS confirmed.
⚠ FOR RESEARCH USE ONLY, PT-141 is supplied exclusively for in vitro and laboratory research applications. Not approved by the FDA for human consumption or therapeutic use. Not a drug, supplement, or medical treatment. Purchasers are responsible for compliance with all applicable regulations.